Bayesian Counterfactual Machine Learning Individualizes Radiation Modality Selection to Mitigate Immunosuppression
JCO Clinical Cancer Informatics · 2025-08 · (9)
DOI: 10.1200/cci-25-00058 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Clinical Cancer Informatics, 2025-08. Verfasst von Duo Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI. Hauptthemen laut MEDLINE: Machine Learning, Immune Tolerance, Lymphopenia, Esophageal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE Lymphocytes play critical roles in cancer immunity and tumor surveillance. Radiation-induced lymphopenia (RIL) is a common side effect observed in patients with cancer undergoing chemoradiation therapy (CRT), leading to impaired immunity and worse clinical outcomes. Although proton beam therapy (PBT) has been suggested to reduce RIL risk compared with intensity-modulated radiation therapy (IMRT), this study used Bayesian counterfactual machine learning to identify distinct patient profiles and inform personalized radiation modality choice. METHODS A novel Bayesian causal inferential technique is introduced and applied to a matched retrospective cohort of 510 patients with esophageal cancer undergoing CRT to identify patient profiles for which immunosuppression could have been mitigated from radiation modality selection. RESULTS BMI, age, baseline absolute lymphocyte count (ALC), and planning target volume determined the extent to which reductions in ALCs varied by radiation modality. Five patient profiles were identified. Significant variation in ALC nadir between PBT and IMRT was observed in three of the patient subtypes. Notably, older patients (age >69 years) with normal weight experienced a two-fold reduction in mean ALC nadir when treated with IMRT versus PBT. Mean ALC nadir was reduced significantly for IMRT patients with lower ALC at baseline (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI.
- Department of Biostatistics, Yale School of Public Health, New Haven, CT.
- Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Department of Epidemiology and Biostatistics, Texas A&M University, College Station, TX.
- Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Telperian, Austin, TX.
ORCID-Profile: Duo Yu, Michael J Kane, Yiqing Chen, Steven H Lin, Brian P Hobbs
Förderung
- NCI NIH HHS
Zitieren
APA
Yu, D., Kane, M. J., Chen, Y., Lin, S. H., Mohan, R., & Hobbs, B. P. (2025). Bayesian Counterfactual Machine Learning Individualizes Radiation Modality Selection to Mitigate Immunosuppression. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci-25-00058
Vancouver
Yu D, Kane MJ, Chen Y, Lin SH, Mohan R, Hobbs BP. Bayesian Counterfactual Machine Learning Individualizes Radiation Modality Selection to Mitigate Immunosuppression. JCO Clinical Cancer Informatics. 2025. doi:10.1200/cci-25-00058
BibTeX
@article{Yu2025,
author = {Yu, Duo and Kane, Michael J and Chen, Yiqing and Lin, Steven H and Mohan, Radhe and Hobbs, Brian P},
title = {Bayesian Counterfactual Machine Learning Individualizes Radiation Modality Selection to Mitigate Immunosuppression},
journal = {JCO Clinical Cancer Informatics},
year = {2025},
number = {9},
doi = {10.1200/cci-25-00058}
}
EUVIMED